News: leukaemia
Closing in on cure for common leukaemia
A groundbreaking leukaemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR) – meaning they are effectively cured of the disease.
Arthritis drug used to limit antibiotics in blood cancer patients
ÌÇÐÄvolgers from the University of Adelaide and the Radboud University Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood cancer, including leukaemia, lymphoma and myeloma.
[Read more about Arthritis drug used to limit antibiotics in blood cancer patients]
Success for Adelaide-led medical research
The University of Adelaide has been awarded more than $8.8 million in research grants from the Federal Government’s Medical ÌÇÐÄvolg Future Fund’s (MRFF) to support targeted research on new ways to address risk factors for chronic and complex diseases.
$1.62 million for rare cancer research
A University of Adelaide and SAHMRI study to test new treatments for a rare and neglected blood cancer, which has no known effective treatment, has been awarded $1,619,122 from the Federal Government’s Medical ÌÇÐÄvolg Future Fund (MRFF).
Major breakthrough for leukaemia treatment
An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia (CML).
[Read more about Major breakthrough for leukaemia treatment]
Investment into incurable blood cancer research
University of Adelaide-led cancer researchers have received $600,000 to help drive rapid advancements in treatments for the incurable blood cancer, myeloma.
[Read more about Investment into incurable blood cancer research]
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}